Subscribe for perks & to support LI

Your Interests & Preferences: Personalise your reading

Which best describes your role and/or interests?

I work in a law firm
I work for a company / in-house
I'm a litigator at the bar
I'm a law student
Aspiring law student
Save setting
Or click here to show more preferences...

I am interested in the following types of stories (uncheck to hide from frontpage)

Firms / In-House
Legal Education

Always show me: (overrides the above)

Exclusives & Editor's Picks

Website Look & Feel

Light Text on Dark Background

Save preferences

Note: Your preferences will be saved in your browser. You can always change your settings by clicking the Your Preferences button at the top of every page.

Reset preferences to defaults?

$3.8bn blockbuster deal: CAM, AZB help HUL buy GSK India’s Horlicks biz

“FMCG major Hindustan Unilever Limited (HUL) on Monday said it will buy GlaxoSmithKline’s Indian Horlicks nutrition business for around $3.8 billion, boosting the consumer goods group’s position in a key emerging market,” reported Firstpost today. The deal covers GlaxoSmithKline Consumer Healthcare, which includes the Horlicks brand and businesses in India, Bangladesh and 20 other markets, mostly in Asia.

Cyril Amarchand Mangaldas managing partner Cyril Shroff and partners Nivedita Rao and Ramgovind Kurupath acted for Hindustan Unilever, alongside partner Ranjan Negi for IP issues, partner Bharat Bhudolia for competition law and partner Daksha Baxi on tax aspects.

AZB & Partners Delhi partner Vinati Kastia, assisted by managing partner Ajay Bahl and partner Ravi Prakash on tax aspects, acted for GlaxoSmithKline. Also advising was partner Daksh Trivedi and counsel Bharat Apte, and lawyers Ankit Tandon, Ayush Tandon, Aman Jain.

Baker & McKenzie acted for Hindustan Unilever on international aspects of the deal.

Slaughter and May acted for GlaxoSmithKline on UK advice.

This deal report is based on a firm's press release and may be only partially complete. Some firms or names of advisers may be therefore be missing.

Click here if you are working with a law firm that has not been credited for this deal, and we will update the report promptly.

Click to show 17 comments
at your own risk
By reading the comments you agree that they are the (often anonymous) personal views and opinions of readers, which may be biased and unreliable, and for which Legally India therefore has no liability. If you believe a comment is inappropriate, please click 'Report to LI' below the comment and we will review it as soon as practicable.

Latest comments